|4Jan 28, 11:23 AM ET

Corkrean John J 4

4 · FULLER H B CO · Filed Jan 28, 2026

Research Summary

AI-generated summary of this filing

Updated

FULLER H B (FUL) CFO John J. Corkrean Receives RSUs, Exercises Options

What Happened

  • John J. Corkrean, Executive Vice President and CFO of Fuller H. B. Co. (FUL), received equity awards and exercised stock options on 2026-01-26. He was granted 39,347 restricted stock units (RSUs) valued at about $2,353,344 (39,347 × $59.81) and an additional 5,804 RSUs reported at $0 (likely settlement/award units). He also exercised options that resulted in 1,404 shares tied to an exercise value of $60.07 per share (total $84,338). Some shares were withheld to cover taxes.

Key Details

  • Transaction date: 2026-01-26; Form 4 filed 2026-01-28 (timely within the two-business-day window).
  • Grants: 39,347 RSUs @ $59.81 each ≈ $2,353,344; plus 5,804 RSUs reported at $0.
  • Option exercise: 1,404 shares at $60.07/share = $84,338 (exercise/conversion reported).
  • Tax/tendering actions: 431 shares withheld for taxes (431 × $60.07 = $25,890). The filing also shows disposition entries related to the exercised shares (reported per Form 4 mechanics).
  • Shares owned after the transactions: not specified in the provided filing excerpt.
  • Relevant footnotes: F1 (shares withheld for taxes on 1,404 shares), F2/F4 (some awards vest in three annual installments: 33%/33%/34%), F3/F7 (RSUs convert 1-for-1 to common stock), F5/F9 (some units include dividend-equivalent features), F6 (one option reported as 100% vested), F8 (certain units convert on termination or as selected subject to holding rules).

Context

  • These entries are mostly compensation-related (RSU grants and option exercises), which are routine for executives and do not necessarily signal buying/selling for investment reasons. The exercise shows acquisition of shares via option conversion, with some shares withheld/tendered to cover taxes or exercise costs (a common cashless exercise/reporting pattern). Grants (RSUs) are acquisitions but typically subject to vesting schedules noted in footnotes.

Insider Transaction Report

Form 4
Period: 2026-01-26
Corkrean John J
Executive VP and CFO
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-26$60.07/sh+1,404$84,33858,940 total
  • Tax Payment

    Common Stock

    [F1]
    2026-01-26$60.07/sh431$25,89058,509 total
  • Award

    Employee Stock Option (Right-to-Buy)

    [F2]
    2026-01-26$59.81/sh+39,347$2,353,34439,347 total
    Exercise: $59.81From: 2027-01-26Exp: 2036-01-26Common Stock (39,347 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F3][F4][F5]
    2026-01-26$60.07/sh1,404$84,3381,448.64 total
    Exercise: $0.00From: 2025-01-26Exp: 2027-01-26Common Stock (1,404 underlying)
  • Award

    Restricted Stock Units

    [F3][F4]
    2026-01-26+5,8045,804 total
    Exercise: $0.00From: 2027-01-26Exp: 2029-01-26Common Stock (5,804 underlying)
Holdings
  • Employee Stock Option (Right-to-Buy)

    [F6]
    Exercise: $45.05From: 2020-01-24Exp: 2029-01-24Common Stock (41,208 underlying)
    41,208
  • Employee Stock Option (Right-to-Buy)

    [F6]
    Exercise: $48.35From: 2021-01-24Exp: 2030-01-24Common Stock (48,309 underlying)
    48,309
  • Employee Stock Option (Right-to-Buy)

    [F6]
    Exercise: $50.10From: 2018-01-26Exp: 2027-01-26Common Stock (23,696 underlying)
    23,696
  • Employee Stock Option (Right-to-Buy)

    [F6]
    Exercise: $51.89From: 2022-01-27Exp: 2031-01-27Common Stock (38,376 underlying)
    38,376
  • Employee Stock Option (Right-to-Buy)

    [F6]
    Exercise: $53.57From: 2019-01-25Exp: 2028-01-25Common Stock (21,834 underlying)
    21,834
  • Employee Stock Option (Right-to-Buy)

    [F2]
    Exercise: $64.28From: 2026-01-27Exp: 2035-01-27Common Stock (24,570 underlying)
    24,570
  • Employee Stock Option (Right-to-Buy)

    [F6]
    Exercise: $68.17From: 2024-01-24Exp: 2033-01-24Common Stock (22,312 underlying)
    22,312
  • Employee Stock Option (Right-to-Buy)

    [F6]
    Exercise: $72.94From: 2023-01-24Exp: 2032-01-24Common Stock (21,997 underlying)
    21,997
  • Employee Stock Option (Right-to-Buy)

    [F2]
    Exercise: $77.72From: 2025-01-26Exp: 2034-01-26Common Stock (24,774 underlying)
    24,774
  • Phantom Units

    [F7][F8][F9]
    Exercise: $0.00Common Stock (28,248.05 underlying)
    28,248.05
  • Restricted Stock Units

    [F3][F4][F5]
    Exercise: $0.00From: 2026-01-27Exp: 2028-01-27Common Stock (4,370.58 underlying)
    4,370.58
Footnotes (9)
  • [F1]Shares withheld for taxes due on 1,404 shares issued.
  • [F2]This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.
  • [F3]These restricted stock units convert into shares of common stock on a 1-for-1 basis.
  • [F4]These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.
  • [F5]Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.
  • [F6]This option is 100% vested.
  • [F7]These units (acquired after 12-31-04) convert into shares of common stock on a 1-for-1 basis.
  • [F8]These units (acquired after 12-31-04) convert into shares of common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.
  • [F9]Amount includes stock units acquired pursuant to a dividend equivalent feature.
Signature
/s/ Patrick J. Seul, Attorney-in-Fact|2026-01-28

Documents

1 file
  • 4
    doc4.xmlPrimary